IVD Office Willing To Swap Premarket Diligence For Risk-Based “Smart Regs”

CDRH's Office of In Vitro Diagnostic Devices Evaluation & Safety anticipates granting more freedom to IVD manufacturers to exchange premarket information for postmarket vigilance measures in device reviews